Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
13 March 2023 - 10:39PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2023
Commission File Number: 001-31368
SANOFI
(Translation of
registrant’s name into English)
46, avenue de
la Grande Armée, 75017 Paris, FRANCE
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
On March 13, 2023, Sanofi published the press release attached hereto as Exhibit 99.1 which is incorporated herein by reference.
Exhibit List
|
|
|
| Exhibit No. |
|
Description |
|
|
| 99.1 |
|
Joint press release issued by Sanofi and Provention Bio, Inc. on March 13, 2023. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
| Dated: March 13, 2023 |
|
|
|
SANOFI |
|
|
|
|
|
|
|
|
By |
|
/s/ Alexandra Roger |
|
|
|
|
Name: |
|
Alexandra Roger |
|
|
|
|
Title: |
|
Head of Securities Law and Capital Markets |
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Apr 2023 to Apr 2024
